215 related articles for article (PubMed ID: 20523340)
21. New insights into the regulation of Na+,K+-ATPase by ouabain.
Silva E; Soares-da-Silva P
Int Rev Cell Mol Biol; 2012; 294():99-132. PubMed ID: 22364872
[TBL] [Abstract][Full Text] [Related]
22. Interaction of palytoxin and cardiac glycosides on erythrocyte membrane and (Na+ + K+) ATPase.
Ozaki H; Nagase H; Urakawa N
Eur J Biochem; 1985 Oct; 152(2):475-80. PubMed ID: 2865137
[TBL] [Abstract][Full Text] [Related]
23. Structure-activity relationships for the hypertensinogenic activity of ouabain: role of the sugar and lactone ring.
Manunta P; Hamilton BP; Hamlyn JM
Hypertension; 2001 Feb; 37(2 Pt 2):472-7. PubMed ID: 11230321
[TBL] [Abstract][Full Text] [Related]
24. 17beta-O-Aminoalkyloximes of 5beta-androstane-3beta,14beta-diol with digitalis-like activity: synthesis, cardiotonic activity, structure-activity relationships, and molecular modeling of the Na(+),K(+)-ATPase receptor.
Cerri A; Almirante N; Barassi P; Benicchio A; Fedrizzi G; Ferrari P; Micheletti R; Quadri L; Ragg E; Rossi R; Santagostino M; Schiavone A; Serra F; Zappavigna MP; Melloni P
J Med Chem; 2000 Jun; 43(12):2332-49. PubMed ID: 10882359
[TBL] [Abstract][Full Text] [Related]
25. Ovine cardiac Na,K-ATPase: isolation by means of selective solubilization in Lubrol and the effect of 1 alpha,2 alpha-epoxyscillirosidin on this enzyme.
Venter PA; Naudé RJ; Oelofsen W; Swan GE
Int J Biochem Cell Biol; 1997; 29(8-9):1103-12. PubMed ID: 9416006
[TBL] [Abstract][Full Text] [Related]
26. A sensitive [Na,K]ATPase assay specific for inhibitors acting through the digitalis-binding site.
Tao QF; Soszynski PA; Hollenberg NK; Graves SW
J Cardiovasc Pharmacol; 1995 Jun; 25(6):859-63. PubMed ID: 7564329
[TBL] [Abstract][Full Text] [Related]
27. Cross-resistance and biochemical studies with two classes of HeLa cell mutants resistant to cardiac glycosides. The unusual behavior of cardenolide SC4453.
Gupta RS; Chopra A
J Biol Chem; 1985 Jun; 260(11):6843-50. PubMed ID: 2987235
[TBL] [Abstract][Full Text] [Related]
28. 2-Methoxy-3,8,9-trihydroxy coumestan: a new synthetic inhibitor of Na+,K+-ATPase with an original mechanism of action.
Pôças ES; Costa PR; da Silva AJ; Noël F
Biochem Pharmacol; 2003 Dec; 66(11):2169-76. PubMed ID: 14609741
[TBL] [Abstract][Full Text] [Related]
29. [The calixarenes C-97 and C-107 stimulate influence of ouabain on the Na+,K+-ATPase activity in plasmatic membrane of smooth muscle cells].
Veklich TO; Shkrabak OA; Kosterin SO; Rodik RV; Cherenok SO; Boĭko SO; Boĭko VI; Kal'chenko VI
Ukr Biokhim Zh (1999); 2006; 78(6):53-63. PubMed ID: 17494319
[TBL] [Abstract][Full Text] [Related]
30. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
Bagrov AY; Fedorova OV
J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
[TBL] [Abstract][Full Text] [Related]
31. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
Tamura M; Harris TM; Konishi F; Inagami T
Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
[TBL] [Abstract][Full Text] [Related]
32. Enhancing the potency of lithospermate B for inhibiting Na+/K+-ATPase activity by forming transition metal ion complexes.
Lin NH; Chung TY; Li FY; Chen HA; Tzen JT
Acta Pharmacol Sin; 2013 Jul; 34(7):893-900. PubMed ID: 23685954
[TBL] [Abstract][Full Text] [Related]
33. Spin-labeled derivatives of cardiotonic steroids as tools for characterization of the extracellular entrance to the binding site on Na
Guo JH; Jiang RW; Andersen JL; Esmann M; Fedosova NU
FEBS J; 2018 Jun; 285(12):2292-2305. PubMed ID: 29688626
[TBL] [Abstract][Full Text] [Related]
34. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
Paula S; Tabet MR; Ball WJ
Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
[TBL] [Abstract][Full Text] [Related]
35. ATP1A1-mediated Src signaling inhibits coronavirus entry into host cells.
Burkard C; Verheije MH; Haagmans BL; van Kuppeveld FJ; Rottier PJ; Bosch BJ; de Haan CA
J Virol; 2015 Apr; 89(8):4434-48. PubMed ID: 25653449
[TBL] [Abstract][Full Text] [Related]
36. Ouabain-sensitive Na+,K(+)-ATPase activity in toad brain.
Morris JF; Ismail-Beigi F; Butler VP; Gati I; Lichtstein D
Comp Biochem Physiol A Physiol; 1997 Nov; 118(3):599-606. PubMed ID: 9406436
[TBL] [Abstract][Full Text] [Related]
37. Depth of the Steroid Core Location Determines the Mode of Na,K-ATPase Inhibition by Cardiotonic Steroids.
Tverskoi AM; Poluektov YM; Klimanova EA; Mitkevich VA; Makarov AA; Orlov SN; Petrushanko IY; Lopina OD
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948068
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of novel sodium/potassium-ATPase inhibitors by virtual screening of a compound database.
Stanton DT; Ankenbauer J; Rothgeb D; Draper M; Paula S
Bioorg Med Chem; 2007 Sep; 15(18):6062-70. PubMed ID: 17618121
[TBL] [Abstract][Full Text] [Related]
39. Biochemical and cross-resistance studies with HeLa cell mutants resistant to cardiac glycoside SC4453. Regulation of the resistant form of Na+/K+-ATPase in the mutant cells.
Chopra A; Gupta RS
J Biol Chem; 1986 Feb; 261(5):2034-40. PubMed ID: 3003091
[TBL] [Abstract][Full Text] [Related]
40. Digitalis structure-activity relationship analyses. Conclusions from indirect binding studies with cardiac (Na+ + K+)-ATPase.
Brown L; Erdmann E; Thomas R
Biochem Pharmacol; 1983 Sep; 32(18):2767-74. PubMed ID: 6313008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
